Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Minipulse and NB-UVB in Vitiligo
NCT04030988Phase 1Unknown
- Sponsor
- Ain Shams University
- Start
- Nov 2018
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Vitiligo comparing Dexamethasone + NB-UVB with Placebo + NB-UVB (2 arms). Primary endpoints: Number of participants with clinical activity of vitiligo at 6 months, Photography to detect activity of vitiligo at 6 months and 2 more. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT04030988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04030988.